{"title":"量化抗菌素暴露:终末期肾脏疾病人群的危害","authors":"G. Snyder, Christopher M. McCoy, E. D’Agata","doi":"10.1017/ice.2016.290","DOIUrl":null,"url":null,"abstract":"Using a rigorously collected data set of antimicrobial use among patients receiving chronic hemodialysis, antimicrobial use was calculated using 3 different methodologies: daily defined dose, days of therapy, and start–stop days. Estimates of antimicrobial use varied by as much as 10-fold, depending on the type of antimicrobial. Infect Control Hosp Epidemiol 2017;38:360–363","PeriodicalId":13655,"journal":{"name":"Infection Control & Hospital Epidemiology","volume":"5 1","pages":"360 - 363"},"PeriodicalIF":0.0000,"publicationDate":"2016-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Quantifying Antimicrobial Exposure: Hazards in Populations With End-Stage Renal Disease\",\"authors\":\"G. Snyder, Christopher M. McCoy, E. D’Agata\",\"doi\":\"10.1017/ice.2016.290\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Using a rigorously collected data set of antimicrobial use among patients receiving chronic hemodialysis, antimicrobial use was calculated using 3 different methodologies: daily defined dose, days of therapy, and start–stop days. Estimates of antimicrobial use varied by as much as 10-fold, depending on the type of antimicrobial. Infect Control Hosp Epidemiol 2017;38:360–363\",\"PeriodicalId\":13655,\"journal\":{\"name\":\"Infection Control & Hospital Epidemiology\",\"volume\":\"5 1\",\"pages\":\"360 - 363\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-12-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Infection Control & Hospital Epidemiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1017/ice.2016.290\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infection Control & Hospital Epidemiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1017/ice.2016.290","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Quantifying Antimicrobial Exposure: Hazards in Populations With End-Stage Renal Disease
Using a rigorously collected data set of antimicrobial use among patients receiving chronic hemodialysis, antimicrobial use was calculated using 3 different methodologies: daily defined dose, days of therapy, and start–stop days. Estimates of antimicrobial use varied by as much as 10-fold, depending on the type of antimicrobial. Infect Control Hosp Epidemiol 2017;38:360–363
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
